{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:01:57Z","timestamp":1777676517078,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116306","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T21:33:21Z","timestamp":1709588001000},"page":"116306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sulfone-based human liver pyruvate kinase inhibitors \u2013 Design, synthesis and in vitro bioactivity"],"prefix":"10.1016","volume":"269","author":[{"given":"Josipa","family":"Mati\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Akladios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto Maria","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"H\u00e5versen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalyn","family":"Nain-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders Foller","family":"F\u00fcchtbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woonghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Monjas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Rodriguez","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Uhlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-4222","authenticated-orcid":false,"given":"Morten","family":"Gr\u00f8tli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116306_bib1","unstructured":"World Health Organization, (2022). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.ejmech.2024.116306_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fendo.2019.00311","article-title":"Countering the modern metabolic disease rampage with ancestral endocannabinoid system alignment","volume":"10","author":"Pepper","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2024.116306_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116306_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymben.2019.01.001","article-title":"Pyruvate kinase L\/R is a regulator of lipid metabolism and mitochondrial function","volume":"52","author":"Liu","year":"2019","journal-title":"Metab. Eng."},{"key":"10.1016\/j.ejmech.2024.116306_bib5","series-title":"Encycl. Biol. Chem.","first-page":"719","article-title":"Pyruvate kinase","author":"Uyeda","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116306_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2024.116306_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/B0-12-227555-1\/00518-9","article-title":"Pyruvate kinases","author":"Oude Weernink","year":"2002","journal-title":"Encycl. Cancer"},{"key":"10.1016\/j.ejmech.2024.116306_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(96)00462-0","article-title":"The allosteric regulation of pyruvate kinase","volume":"389","author":"Mattevi","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2024.116306_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0020-711X(78)90027-7","article-title":"Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties","volume":"9","author":"Hall","year":"1978","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.ejmech.2024.116306_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114270","article-title":"Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase","volume":"234","author":"Nain-Perez","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116306_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/nu15030577","article-title":"Ellagic acid and its metabolites as potent and selective allosteric inhibitors of liver pyruvate kinase","volume":"15","author":"Battisti","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2024.116306_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115177","article-title":"Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators","volume":"250","author":"Nain-Perez","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116306_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/270418","article-title":"Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far","author":"Esp\u00edn","year":"2013","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.ejmech.2024.116306_bib14","first-page":"668","article-title":"Exploration of novel urolithin C derivatives as non-competitive inhibitors of liver pyruvate kinase","volume":"16","author":"Battisti","year":"2023","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2024.116306_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ddtec.2004.10.009","article-title":"Scaffold hopping","volume":"1","author":"B\u00f6hm","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2024.116306_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","article-title":"Classification of scaffold-hopping approaches","volume":"17","author":"Sun","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116306_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.aihch.2020.10.003","article-title":"Cyclic sulfoxides and sulfones in drug design","volume":"134","author":"Regueiro-Ren","year":"2021","journal-title":"Adv. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2024.116306_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/1389200033489253","article-title":"Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist","volume":"4","author":"Beaumont","year":"2005","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2024.116306_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116306_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/ol0480123","article-title":"Double reduction of cyclic aromatic sulfonamides: a novel method for the synthesis of 2- and 3-aryl-substituted cyclic amines","volume":"7","author":"Evans","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.116306_bib21","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1039\/C7NJ02328F","article-title":"\u0392-: O -4 type dilignol compounds and their iron complexes for modeling of iron binding to humic acids: synthesis, characterization, electrochemical studies and algal growth experiments","volume":"41","author":"Orlowska","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2024.116306_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/cb700019r","article-title":"Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase B\u03b1","volume":"2","author":"Mills","year":"2007","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116306_bib23","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.bmc.2010.04.096","article-title":"Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating \u03b1-asarone-based HMG-CoA reductase inhibitors","volume":"18","author":"Arg\u00fcelles","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116306_bib24","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/adsc.201200793","article-title":"Palladium-catalysed intramolecular direct arylation of 2- bromobenzenesulfonic acid derivatives","volume":"354","author":"Bheeter","year":"2012","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2024.116306_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/C3OB41810C","article-title":"Synthesis of benzosultams via an intramolecular sp2 C-H bond amination reaction of o-arylbenzenesulfonamides under metal-free conditions","volume":"12","author":"Li","year":"2014","journal-title":"Org. Biomol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424001867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:59:33Z","timestamp":1759330773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424001867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":25,"alternative-id":["S0223523424001867"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116306","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfone-based human liver pyruvate kinase inhibitors \u2013 Design, synthesis and in vitro bioactivity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116306"}}